Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Breast Neoplasms 5Prostatic Neoplasms 4Multiple Myeloma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Mycosis Fungoides 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Hairy Cell 3Leukemia 3Hodgkin Disease 3Head and Neck Neoplasms 3Brain Neoplasms 3Blast Crisis 3Melanoma 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Dexamethasone 12Palonosetron 11Aprepitant 11Ondansetron 8Olanzapine 5Calcium Dobesilate 4netupitant 2fosaprepitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2yangzheng xiaoji 1rolapitant 1ramosetron 1niraparib 1netupitant, palosentron drug combination 1nabiximols 1isatuximab 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Paclitaxel 1Oxaliplatin 1Octreotide 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nausea × Therapeutics × Clear all
NCT01534637 2018-08-15

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Wake Forest University Health Sciences

Phase 2 Completed
22 enrolled 9 charts
Gastrointestinal

Bile Duct Neoplasms, Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡